Clinical TrialID 382
Evaluation of Artemisia Annua and Moringa
NCT03366922
HIV Infections
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 382
- Evidence Id
- 382
- Core Evidence Id
- 382
- Source Clinical Trial Id
- 369
- Herb2 Clinical Trial Id
- HBCT000369
- Nct Id
- NCT03366922
- Title
- Evaluation of Artemisia Annua and Moringa
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- HIV Infections
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
- Intervention
- DIETARY_SUPPLEMENT: Artemisia Annua, Moringa oleifera
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 250
- Outcome Measure
- CD4 counts, The primary outcome will be change in CD4 counts (absolute and relative) at 6 and 12 months in study participants following enrollment in the study., Baseline, 6 and 12 months
- Sponsor Collaborator
- Mbarara University of Science and Technology|ANAMED
- Funded By
- OTHER
- Location
- Mbarara Regional Referral Hospital, Mbarara, SouthWestern, 00256, Uganda
- Other Id
- 27/05-17
- Start Date
- 2017-12-10
- Primary Completion Date
- 2020-08-10
- Completion Date
- 2020-08-10
- First Posted
- 2017-12-08
- Results First Posted
- Last Update Posted
- 2020-11-20
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03366922
- Title Cn
- Title En
- Evaluation of Artemisia Annua and Moringa
- Bilingual Status
- semi_complete